Psychology by BogdanovaThe Encyclopedia of Psychology for the Artificial Era

RESEARCH DOSSIER

Feeding and Eating Disorders

Abstract. Feeding and eating disorders comprise heterogeneous disturbances of intake and eating-related behavior that threaten physical health, psychological functioning, and social participation. This critical narrative research monograph examines anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant/restrictive food intake disorder, pica, rumination disorder, and other clinically significant presentations. It reconstructs the field's clinical history and diagnostic development and critically synthesizes evidence on epidemiology, developmental and sociocultural contexts, learning and emotion, body image, genetic and neurobiological vulnerability, measurement, medical complications, and clinical management. Historical articles, population surveys, original randomized treatment and prevention trials, reviews, and professional guidelines are analyzed with attention to study design, causal inference, clinical relevance, replication, and generalizability. The evidence supports multidisciplinary assessment and defined psychological interventions, while revealing unresolved questions about mechanistic heterogeneity, understudied feeding disorders, long-term recovery, and equitable delivery of care. Artificial Era technologies are considered as prospective research contexts requiring independent evidence and safety evaluation.

Keywords: feeding and eating disorders; anorexia nervosa; bulimia nervosa; binge-eating disorder; ARFID; rumination disorder; pica; eating disorder psychopathology; cognitive behavioral therapy; family-based treatment; medical complications; eating disorder assessment; clinical psychology; Artificial Era

Introduction: The Clinical and Scientific Problem

Feeding and eating disorders are clinically significant disturbances of eating, food intake, or eating-related behavior that compromise physical health, psychological functioning, or social participation. Their scientific study encompasses patterns of sustained restriction, recurrent binge eating, compensatory behavior, sensory-based food avoidance, ingestion of nonfood substances, and regurgitation. The boundaries of this field have broadened substantially as diagnostic research has recognized that eating disturbance can arise through several different pathways. The National Institute of Mental Health describes these conditions as potentially serious illnesses requiring coordinated attention to psychological, medical, and nutritional functioning NIMH (n.d.).

The central question of this monograph concerns how feeding and eating disturbances emerge, become self-sustaining, differ across syndromes, and respond to interventions. An adequate explanation must connect cultural exposure, emotion regulation, cognitive processes, learning, development, family interaction, biological vulnerability, and bodily consequences while preserving the evidence supporting each level. Diagnosis is an important clinical convention, but epidemiologic classification, mechanistic theory, and individual formulation are separate analytical operations. The American Psychiatric Association's current practice guideline supports structured assessment and disorder-specific treatment decisions rather than a single undifferentiated model Crone et al. (2023).

This work uses a critical narrative synthesis of identified primary trials, historical scholarship, epidemiologic studies, genetic research, measurement studies, systematic reviews, and professional guidelines. It reports the design and interpretation of key findings without implying a prospectively registered systematic-review search or a new meta-analysis. It also distinguishes statistically established associations from experimentally tested treatment mechanisms. The research object is the broad family of disorders, with each syndrome examined as a distinct clinical pattern and as part of a partially overlapping psychopathology domain.

Historical Foundations and the Evolution of Clinical Concepts

Historical descriptions of severe food refusal long preceded modern diagnostic systems. Richard Morton's seventeenth-century accounts of wasting associated with emotional disturbance are often cited as early clinical observations, while nineteenth-century medical descriptions established more recognizable boundaries for anorexia nervosa. Charles Lasègue's 1873 discussion and William Gull's 1873–1874 presentations emerged within different national clinical traditions. Historians have shown that assigning unique priority to either investigator oversimplifies an intertwined chronology of observation, publication, and terminology Pearce (2004) Vandereycken & van Deth (1989).

The twentieth century expanded the field beyond restrictive self-starvation. Gerald Russell's 1979 clinical account described a syndrome involving recurrent overeating, fear of weight gain, and compensatory practices, helping define bulimia nervosa as a separate object of clinical investigation. His original cases established a descriptive cluster and raised hypotheses about cycles of binge eating and purging; the interpretation of those cases must be separated from later randomized evidence about mechanisms and treatment Russell (1979). Binge eating without regular compensatory behavior subsequently acquired greater recognition as a distinct research and diagnostic problem.

The history of feeding disorders follows partly different traditions, particularly developmental pediatrics, nutrition, behavioral assessment, and studies of swallowing or sensory responses. Contemporary classification brings these pathways into a shared scientific framework while allowing crucial differences between fear of weight gain, sensory aversion, low appetite, and learned avoidance. The historical lesson concerns revision: a syndrome name preserves a research lineage, while its precise criteria and presumed causes may change as investigators accumulate better descriptive, longitudinal, and experimental evidence Kambanis & Thomas (2023).

Diagnostic Architecture and Conceptual Boundaries

Current clinical frameworks distinguish anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant/restrictive food intake disorder (ARFID), pica, and rumination disorder, together with specified and unspecified presentations. These names capture meaningful patterns of behavior and impairment but do not imply that every patient fits a uniform psychological profile. Disorders can change presentation over time, and symptoms may occur below categorical diagnostic thresholds. A scientific account therefore tracks both diagnoses and dimensions, including food restriction, binge frequency, compensatory behavior, nutritional consequences, body-image overvaluation, and functional impairment Crone et al. (2023) NIMH (n.d.).

A clinically important distinction separates eating disorders organized around fear of weight gain or body-shape evaluation from restrictive intake associated with sensory properties, limited interest in eating, or concern about aversive consequences such as choking. ARFID can produce severe nutritional compromise without the motivational pattern central to anorexia nervosa. It can also coexist with other neurodevelopmental and psychiatric conditions, complicating causal interpretation. The ARFID review by Kambanis and Thomas emphasizes unresolved questions about interviews, nutrient assessment, and the limited trial evidence available for treatment Kambanis & Thomas (2023).

Diagnostic classifications are practical decision frameworks. The threshold at which a recurrent behavior becomes a disorder depends on distress, impairment, clinical consequences, exclusion criteria, and the definition applied. These thresholds affect who enters epidemiological surveys and clinical trials. Comparing studies therefore requires attention to version-specific diagnostic criteria, recruitment context, and operational definitions before prevalence or treatment outcomes can be combined. A patient with serious medical instability warrants assessment based on clinical condition, even when a scale score or categorical label is ambiguous NICE (2017; updated 2025) Crone et al. (2023).

Anorexia Nervosa: Restriction, Fear, and Medical Risk

Anorexia nervosa involves persistent restriction relative to energy requirements, significantly low weight in the relevant developmental context, and characteristic disturbances in weight-related fear, behavior, or body experience. Psychological investigations consider the role of rigid rules, valuation of shape and weight, perceived control, habit formation, threat anticipation, interoception, and reinforcement. A person's visible weight conveys only part of the clinical picture: rapid change, physiological instability, eating-related beliefs, and functional consequences matter. Modern diagnostic and treatment guidelines make assessment of medical risk an integral part of understanding the disorder Crone et al. (2023) NICE (2017; updated 2025).

Restriction alters bodily state and can in turn intensify cognitive inflexibility, preoccupation with food, impaired concentration, emotional dysregulation, and behavioral rigidity. This creates a methodological challenge because behaviors measured during malnutrition may be consequences of energy deprivation, preexisting vulnerabilities, or reciprocal processes. Simple cross-sectional comparisons with healthy controls cannot establish their temporal order. Genetic evidence supports a partly shared metabolic and psychiatric liability, but associated loci do not establish a deterministic individual pathway or a single biological cause Watson et al. (2019).

Treatment trials also reveal the limits of a purely psychological or purely medical analysis. For adolescents, family-based treatment has stronger evidence than some individual alternatives on particular follow-up remission outcomes, as shown in Lock and colleagues' 121-participant randomized study Lock et al. (2010). For adults, psychological treatment, nutritional rehabilitation, and medical monitoring must be coordinated. Severe physical complications can include cardiovascular, gastrointestinal, endocrine, and metabolic disturbances, and the pace and setting of restoration require qualified clinical judgment rather than generic instructions Westmoreland et al. (2016) NICE (2017; updated 2025).

Bulimia Nervosa: Binge–Compensation Cycles

Bulimia nervosa is characterized by recurrent binge-eating episodes accompanied by inappropriate compensatory practices and a pronounced role for body shape or weight in self-evaluation. Binge eating involves both consumption and a subjective loss of control; the amount eaten and the conditions under which an episode occurs require careful operational definition. Compensatory strategies can include vomiting, misuse of medicines, fasting, or excessive exercise, and their health effects differ. Russell's early work documented the clinical importance of repeated cycles and of associated physical consequences Russell (1979).

Transdiagnostic cognitive-behavioral formulations emphasize how rigid dietary rules, evaluative concerns, emotional responses, and compensatory behavior can interact. A lapse from an inflexible dietary rule may facilitate a binge episode, which is then followed by guilt or anxiety and renewed restriction. This is a clinically useful maintenance hypothesis rather than a complete explanation for every case. Controlled treatment research provides stronger evidence that structured cognitive-behavioral interventions can reduce eating-disorder psychopathology than it provides for each proposed micro-mechanism in isolation Fairburn et al. (2009) Fairburn et al. (2015).

Among adolescents with bulimia nervosa or partial presentations, a two-site trial compared family-based treatment, cognitive-behavioral therapy adapted for adolescents, and supportive psychotherapy. The 130-participant study reported higher short-term abstinence from binge eating and purging for family-based treatment than for the cognitive-behavioral comparison at the end of treatment and at six-month follow-up Le Grange et al. (2015). These findings depend on the particular treatment manuals, outcome definition, age group, and trial context. They do not establish that one intervention is universally best across all patients and service settings.

Binge-Eating Disorder and the Meaning of Loss of Control

Binge-eating disorder involves recurrent episodes of consuming an unusually large quantity of food with a sense of loss of control and associated distress, without the recurrent compensatory practices defining bulimia nervosa. Research must distinguish objective eating quantity from the experience of inability to stop and from ordinary overeating. The distinction matters because laboratory meals, daily diaries, diagnostic interviews, and self-report scales may capture different dimensions. Binge eating can occur across body sizes, and body mass is not a diagnostic substitute for eating-related psychopathology Udo & Grilo (2018) NIMH (n.d.).

Psychological models examine negative affect, reward sensitivity, restraint, emotional coping, habit, interpersonal context, and learned associations. These processes may contribute differently to the onset and persistence of binge eating. Cross-sectional correlations between distress and eating episodes can support candidate explanations, but temporal and experimental designs are needed to distinguish whether distress precedes eating, follows it, or reflects shared determinants. Guideline recommendations give priority to focused psychological interventions, including guided self-help and cognitive-behavioral approaches, while recognizing the need to assess comorbidity and patient context NICE (2017; updated 2025) Crone et al. (2023).

Pharmacological trials provide an additional evidence stream. In a randomized placebo-controlled study involving adults with moderate to severe binge-eating disorder, McElroy and colleagues observed reduced binge-eating days with specified lisdexamfetamine study conditions, accompanied by a higher frequency of treatment-emergent adverse events in active-treatment groups McElroy et al. (2015). Trial results establish population-level benefit–risk observations under eligibility and monitoring rules; they cannot be converted into individualized prescribing guidance. Comparative effectiveness, durability, access, and possible adverse effects remain central questions NICE (2017; updated 2025).

Avoidant/Restrictive Food Intake Disorder

ARFID identifies clinically consequential food avoidance or restriction driven by factors other than a desire to change body shape or weight. Recognized pathways include low interest in food, sensory sensitivity to texture, taste, smell, or appearance, and fear of adverse events such as choking or vomiting. These pathways may coexist, vary across development, and lead to inadequate intake, nutritional deficiency, dependence on supplements or assisted feeding, and major psychosocial impairment. Kambanis and Thomas describe both the promise of mechanism-focused assessment and the difficulty of measuring heterogeneous presentations within one diagnostic category Kambanis & Thomas (2023).

The explanatory mechanisms of ARFID are frequently situated at the intersection of learning, sensory processing, gastrointestinal experience, anxiety, and family mealtime dynamics. A frightening ingestion event may acquire conditioned predictive value; sensory aversion may reflect persistent perceptual differences; low appetite may coexist with altered internal cue awareness. The relative role of these pathways must be established for the individual rather than inferred from the label. Medical examination also has to consider gastrointestinal, swallowing, allergic, and other conditions that could produce or intensify avoidance NIMH (n.d.) Kambanis & Thomas (2023).

The treatment literature is developing. Cognitive-behavioral and family-oriented approaches, exposure to feared foods or sensations, nutritional rehabilitation, and coordinated pediatric care are described in the literature. Yet the evidence base includes many small samples, observational series, and early trials; this is a different level of certainty from established trials for adult bulimia or binge eating. Clinical improvements in specialized cohorts are encouraging, while broad generalization across ages, comorbidities, and service environments remains uncertain Kambanis & Thomas (2023).

Pica and Rumination Disorder

Pica involves persistent ingestion of nonnutritive, nonfood substances in circumstances where the behavior is developmentally inappropriate and requires clinical evaluation. Rumination disorder involves repeated regurgitation of food that may be rechewed, reswallowed, or expelled after other explanations are considered. These patterns cannot be adequately analyzed using only the dietary-restraint or body-image constructs developed for anorexia and bulimia. Relevant disciplines include developmental medicine, behavioral psychology, gastroenterology, dentistry, toxicology, and nutrition. Their inclusion in contemporary feeding-and-eating classification reflects the clinical importance of impaired intake and its consequences NIMH (n.d.).

The study of pica requires attention to developmental status, environmental exposure, sensory reinforcement, possible micronutrient disturbances, cultural context, and safety risks associated with ingested substances. The investigation of rumination involves differentiation from gastroesophageal conditions, vomiting disorders, and other gastrointestinal phenomena. For each, the clinical sequence of antecedents, observable actions, consequences, and functional impairment is a more productive research unit than a generic claim that disordered eating is caused by body dissatisfaction. Risk differs markedly according to substance, frequency, nutritional status, and underlying disease.

Evidence for specialized interventions often comes from smaller behavioral case series or multidisciplinary clinical practice rather than large, disorder-specific randomized trials. Behavioral approaches may target antecedent control, competing responses, and environmental conditions; medical interventions address complications and comorbidity where indicated. The scientific priority is rigorous differential diagnosis and externally valid evaluation of long-term outcomes. Subsuming these disorders into a generalized eating-disorder treatment algorithm would erase clinically consequential differences Crone et al. (2023) NIMH (n.d.).

Other Specified Presentations and Diagnostic Fluidity

Other specified and unspecified feeding or eating disorders refer to clinically consequential symptoms that do not meet every formal threshold for a named syndrome or whose documentation is incomplete. Examples may involve atypical anorexic presentations, limited-frequency bingeing or purging, or other distinctive combinations of symptoms. Such presentations can cause substantial distress, medical risk, and functional impairment. Research that defines severity only by meeting all criteria for a prototypical syndrome risks excluding important patients and underestimating service needs. Clinical guidelines emphasize attention to presentation, health status, and impairment across categorical boundaries NICE (2017; updated 2025) Crone et al. (2023).

Longitudinal studies must also confront diagnostic migration. An individual may move between restrictive, binge-eating, and mixed patterns across time, and treatment may change symptom prominence without removing all psychopathology. Such change complicates the interpretation of remission, recurrence, and incidence. When an apparent new diagnosis follows earlier symptoms, investigators need to determine whether this is a new disorder, evolution of one process, or a classificatory effect. The ability of transdiagnostic cognitive-behavioral therapy to work across diagnostic groups is relevant to these shared processes but does not erase syndrome-specific medical requirements Fairburn et al. (2009).

A credible dimensional analysis uses explicit observable variables, repeated measures, and reliable definitions of exposure and outcome. It compares the predictive utility of categorical diagnosis against measurements of restriction, compensatory behavior, perceived loss of control, and functional disruption. Hierarchical models may improve prediction, but their value depends on prospective testing and stable measurement across cohorts. The classification itself is a research instrument whose sensitivity and limitations should be measured, particularly when decisions about care depend on threshold conventions Cooper et al. (1989) Udo & Grilo (2018).

Epidemiology, Prevalence, and Population Burden

The frequency of feeding and eating disorders is sensitive to diagnostic definitions, sampling procedures, participant age, gender representation, and the time window used. Population estimates describing point prevalence, twelve-month prevalence, and lifetime prevalence answer different questions. In a systematic review of studies published over the 2000–2018 period, Galmiche and colleagues found substantial heterogeneity among 94 investigations applying more narrowly defined diagnoses and a further 27 using broader definitions. The difference between these study groups illustrates why a single unqualified global percentage would misrepresent the underlying literature Galmiche et al. (2019).

Udo and Grilo analyzed a nationally representative U.S. adult sample using DSM-5-defined categories. Their study matters methodologically because representative sampling and structured diagnostic definitions address weaknesses of convenience samples drawn primarily from specialist clinics or student populations. Yet it remains geographically and historically specific. Survey nonresponse, self-report disclosure, interviewer method, and the distinction between clinical disorders and symptoms influence inference. It is therefore essential to report the population, observation period, classification, and age group alongside any numerical prevalence estimate Udo & Grilo (2018).

Conventional burden accounting may also miss presentations that lack a reliable diagnostic interview in older datasets, including some cases of ARFID and other specified disorders. Comparisons across countries face differences in clinical recognition, stigma, cultural expression, and health-system access. Rising ascertainment can reflect genuine changes, measurement revision, greater awareness, and altered help-seeking. Investigators should seek consistency across repeated surveys with harmonized definitions before claiming a true secular increase in underlying incidence Galmiche et al. (2019).

Developmental Course and Adolescent Vulnerability

Adolescence is a major developmental context for the emergence of body-image concerns, changing nutritional needs, greater peer salience, and heightened sensitivity to appearance-related social evaluation. Pubertal timing, family transitions, sports participation, identity development, and digital media exposure can intersect with individual liability. Early emergence does not imply that all eating disorders begin during adolescence; the developmental distribution varies by subtype, and ARFID can appear in childhood. The evidence supports examining onset and maintenance at successive developmental stages rather than treating age as a peripheral demographic adjustment Galmiche et al. (2019) NIMH (n.d.).

Adolescent treatment research is also shaped by the family and developmental environment. Lock and colleagues randomized 121 adolescents with anorexia nervosa to family-based or adolescent-focused individual therapy; the reported follow-up advantage of family-based treatment informs care for the trial population and related presentations Lock et al. (2010). Le Grange and colleagues' trial in adolescent bulimia demonstrates that family-involved approaches can be tested against an active psychological alternative using predefined behavioral outcomes Le Grange et al. (2015). Neither finding implies parental causation of the disorder, and family engagement should be understood as a therapeutic resource and contextual factor.

Developmental methodology requires attention to growth trajectories and individualized medical interpretation. Static adult weight criteria, unadjusted body mass index, and brief symptom snapshots may inadequately capture adolescent nutritional compromise. Functional impact includes interruption of education, friendships, autonomy, and normative developmental participation. Long-term studies should examine whether improvement in eating symptoms predicts restoration of these broader functions and whether early intervention modifies adult trajectories rather than merely improving short-term questionnaire scores Crone et al. (2023) NICE (2017; updated 2025).

Medical Complications and the Bidirectional Body–Mind System

The medical consequences of eating disorders vary by nutritional restriction, rapid weight change, purging, bingeing, comorbidity, and duration. Undernutrition can affect cardiovascular, endocrine, skeletal, gastrointestinal, and neurological functioning. Recurrent vomiting or medication misuse can cause electrolyte disturbance, dehydration, and other physiological complications. Some hazards may appear despite an unremarkable external appearance or a body weight that does not appear very low. Westmoreland, Krantz, and Mehler provide a clinical review of complications in anorexia and bulimia that underscores the importance of examining observable medical state alongside mental symptoms Westmoreland et al. (2016).

The relationship between psychological phenomena and physical condition is reciprocal. Nutritional deprivation may modify attention, sleep, motivation, affect, thermoregulation, and the ability to participate in psychotherapy. Anxiety, rigidity, and avoidance may then obstruct restoration of adequate intake, reinforcing the original physiological disturbance. Observing these processes simultaneously cannot by itself establish which component preceded the other. Repeated within-person measurements and appropriately controlled intervention studies are needed to disentangle premorbid traits from state-dependent consequences Crone et al. (2023).

Refeeding during significant malnutrition is a clinically important medical process. The American Society for Parenteral and Enteral Nutrition's consensus recommendations discuss the risk of electrolyte and metabolic complications after nutrition is reintroduced, and propose monitoring and risk-stratification principles for hospitalized populations da Silva et al. (2020). The guideline is not a substitute for individualized medical care. This monograph therefore examines safety as a research and clinical governance concern, without specifying caloric schedules, electrolyte regimens, or other instructions that require qualified assessment of an individual.

Cognitive-Behavioral and Transdiagnostic Mechanisms

Contemporary cognitive-behavioral theories analyze how beliefs about eating, body shape, weight, self-control, and personal value interact with repeated actions and their consequences. A restrictive rule may initially reduce anxiety or produce a feeling of mastery, thereby reinforcing itself. As physiological deprivation, social withdrawal, or perceived rule violations accumulate, the same pattern can intensify distress and diminish flexible behavioral alternatives. Transdiagnostic models emphasize common maintaining processes across anorexia, bulimia, and other presentations, while acknowledging differences in nutritional state and diagnostic context. Fairburn and colleagues' two-site intervention trial offers clinically relevant evidence for treating these shared processes Fairburn et al. (2009).

Theoretical specificity requires distinguishing an explanatory network from the success of an intervention. A treatment package can outperform a comparison while its proposed causal mediators remain incompletely established. For example, improvement in shape-related overvaluation may accompany symptom improvement because both respond to therapy, because one mediates the other, or because a third process changes. Factorial experiments, repeated temporal mediation analysis, and sufficiently powered trials that manipulate specific techniques would clarify these pathways. The stronger conclusion from a successful package trial is that the tested package changed defined outcomes in the studied population Fairburn et al. (2015).

Psychological mechanisms also vary within diagnoses. Some patients experience marked cognitive dietary restraint; others report strong affective triggers, entrenched habits, or interpersonal crises. ARFID has mechanisms involving sensory processing and fear learning that often require different theoretical constructs. Effective case formulation therefore integrates diagnosed symptoms with observed contingencies, developmental history, medical state, and changing environmental demands. The scientific task is to identify which constructs improve prediction and response to treatment beyond broad diagnostic membership Kambanis & Thomas (2023) Crone et al. (2023).

Body Image, Self-Evaluation, and Sociocultural Processes

Body image is a multidimensional construct that includes perception, evaluation, emotion, attention, and behavior toward one's body. Its contribution to eating disorder psychopathology is especially important when weight or shape occupies a disproportionate role in self-worth. Researchers examine dissatisfaction, appearance comparison, internalization of prevailing ideals, checking and avoidance behaviors, and their interaction with restrictive eating. These dimensions overlap but should not be treated as interchangeable variables. Cross-sectional evidence establishes associations, whereas prospective and experimentally manipulated exposures provide stronger grounds for causal inference Stice et al. (2006) Fairburn et al. (2009).

Sociocultural pathways include peers, family commentary, marketing, athletic norms, and digital environments. Their effects may depend on the meaning an individual assigns to appearance and on prior vulnerability. Experimental prevention programs that invite participants to critique narrow appearance ideals provide one route for testing whether shifting internalization can change related risk factors. Stice and colleagues' randomized prevention trial reported improvements in several risk indicators and bulimic symptoms relative to selected controls, although comparative effects varied over follow-up Stice et al. (2006). This literature supports a modifiable psychosocial pathway without supporting a monocausal media explanation.

Body-image scholarship must also be culturally and developmentally attentive. Dominant measurement instruments were often constructed in particular language communities and with female clinical samples. The meaning of appearance, muscularity, restraint, body modification, and stigma may differ among groups. Measurement invariance and culturally valid qualitative interviews are necessary before score comparisons are interpreted as genuine differences in psychopathology. The biological and medical dimensions of an eating disorder remain important even when explicit body dissatisfaction is absent, as ARFID research demonstrates Kambanis & Thomas (2023) Udo & Grilo (2018).

Emotion Regulation, Interoception, and Reinforcement

Emotion regulation refers to processes that shape which emotions arise, how they are interpreted, and how people respond to them. In eating disorders, restriction, bingeing, and compensatory actions may sometimes serve immediate regulatory functions, such as distraction, numbing, perceived safety, or reduction of shame. These short-term consequences can reinforce a behavior despite adverse effects on long-term health. The explanatory plausibility of this model is high, but the strength and sequence of the associations differ across syndromes and individuals. Eating-related distress can also be a consequence of behavior, complicating causal interpretation Fairburn et al. (2009).

Interoception concerns the sensing and interpretation of internal bodily signals, including hunger, fullness, visceral discomfort, and arousal. Studies may assess subjective reporting, behavioral decisions, and physiological measures, but these methods do not automatically measure the same latent process. In a malnourished patient, altered appetite experience may reflect current nutritional state; in ARFID, anticipated gastrointestinal discomfort or sensory sensitivity may shape avoidance before eating begins. A rigorous account distinguishes body-signal detection, conscious interpretation, prediction, and action selection Kambanis & Thomas (2023) NIMH (n.d.).

To evaluate emotion and interoception mechanisms, researchers can use ecological momentary assessment, prospective diaries, laboratory tasks, and repeated physiological measures. Such studies may reveal within-person temporal patterns that a retrospective interview obscures, but they remain vulnerable to incomplete sampling and reactivity. Experiments that alter environmental cues, stressors, or learning contingencies can complement observational designs. The goal is to establish mechanisms whose modification changes clinically meaningful outcomes while preserving patient safety and respecting differences in medical condition Crone et al. (2023).

Genetic, Neurobiological, and Metabolic Research

Biological investigations of eating disorders include inherited liability, neuroendocrine regulation, reward learning, stress physiology, and mechanisms of energy homeostasis. The genome-wide association study reported by Watson and colleagues in 2019 identified eight loci associated with anorexia nervosa and implicated genetic correlations spanning psychiatric and metabolic traits Watson et al. (2019). This is important evidence against explaining the syndrome entirely through cultural appearance norms. However, genetic association identifies statistical relationships in studied populations, not a necessary sequence of molecular events or a reliable individual diagnostic test.

Neuroimaging and experimental neuroscience have produced hypotheses involving valuation of food, habit learning, cognitive control, threat processing, and sensory integration. Interpretation is complicated by sample size, medication, body composition, the consequences of starvation, and the clinical heterogeneity of recruited groups. A neural activation difference can reflect symptom expression, compensation, or comorbidity rather than a causal abnormality. Prospective high-risk cohorts, repeated measures before and after nutritional rehabilitation, and preregistered multimodal designs offer more credible tests of state and trait hypotheses than isolated cross-sectional contrasts Watson et al. (2019).

Metabolic findings deepen the need for multidisciplinary synthesis. Nutritional deficits change endocrine function and energy expenditure, while behavior and emotional processes influence intake and activity. Yet claims about an integrated 'metabo-psychiatric' origin should be translated into testable pathways rather than treated as a complete clinical explanation. Current professional guidance still requires a combined assessment of mental state, nutritional status, physical stability, and functional impairment; no single biomarker replaces this examination Crone et al. (2023) Westmoreland et al. (2016).

Learning, Habits, Environmental Cues, and Food Avoidance

Learning theories contribute a common language for analyzing how eating behavior changes through experience. Classical conditioning can help explain anticipatory fear surrounding particular foods or sensations; instrumental learning describes how avoidance or compensatory actions may be sustained by immediate relief. Habit accounts consider whether repeated action becomes less sensitive to changes in intended outcomes. These hypotheses can apply to different behaviors without asserting one uniform causal process. Their usefulness depends on specifying cues, responses, reinforcers, and alternative explanations at the level actually measured Kambanis & Thomas (2023) Fairburn et al. (2009).

Environmental context matters because eating occurs within routines, availability constraints, relationships, cultural norms, and bodily states. The same individual may experience difficulty during unstructured meals, social eating, travel, or periods of stress. Laboratory behavior can clarify specific mechanisms but may not generalize to real-life settings that include uncertainty and interpersonal evaluation. Ecologically informed designs can combine momentary context, behavior, appetite, and emotion; repeated observations can also identify when avoidance or binge episodes are more likely without assuming an immutable trait.

Treatments based on behavioral learning may involve gradual and supported changes in food-related behavior, but their clinical implementation depends on diagnosis and medical stability. An exposure-based intervention relevant to sensory or feared-consequence avoidance cannot simply be transferred to all restrictive disorders. A productive research agenda compares mechanisms across conditions through common measures while testing tailored interventions in groups defined by the mechanisms they actually display. Such designs may improve treatment matching more reliably than purely categorical assumptions Kambanis & Thomas (2023) NICE (2017; updated 2025).

Interpersonal Relationships, Family Systems, and Social Functioning

Eating disorders alter relationships through secrecy, conflict, distress around meals, caregiving demands, withdrawal, and difficulty negotiating autonomy. These effects can also shape the course of illness by changing opportunities for support, reducing social participation, or intensifying anxiety. Family studies must avoid confusing family reactions to an existing disorder with family factors that preceded onset. The clinical utility of working with caregivers can be substantial even when causal models of family origin are uncertain. Randomized evidence from adolescent anorexia demonstrates that a structured family-based approach can improve particular remission outcomes Lock et al. (2010).

Family-based treatment studies define a specific therapeutic strategy rather than proving that relatives are responsible for the problem. In the adolescent bulimia trial by Le Grange and colleagues, the comparison was between defined interventions delivered within specialist services Le Grange et al. (2015). Outcomes may depend on treatment fidelity, availability of caregivers, developmental stage, and the practical conditions of participation. Research should examine accessibility for diverse household structures and the impact of coercion, conflict, stigma, or insufficient social support where these factors are present.

Interpersonal processes also influence treatment engagement and outcomes among adults. Isolation, perceived judgment, financial constraints, intimate partnerships, workplace participation, and health-system relationships can shape both help-seeking and recovery. Clinical assessments should evaluate functioning and treatment preferences alongside symptom scores. The scientific question extends to whether improvements in social roles precede, follow, or reciprocally interact with changes in eating behaviors. Without longitudinal measurement, correlation between impairment and illness severity cannot resolve that question Crone et al. (2023).

Clinical Interviews, Screening, and Psychometric Measurement

Clinical measurement begins by specifying the construct under investigation. Screening tools flag possible cases for additional evaluation, diagnostic interviews establish the fit of symptoms to formal criteria, and symptom scales can track change over time. These functions demand different forms of validity. The Eating Disorder Examination was developed as a semistructured interview of eating-related psychopathology; Cooper, Cooper, and Fairburn reported discrimination between eating-disorder patients and controls in early validation work Cooper et al. (1989). Interpretation must account for the historical clinical samples on which instruments were originally evaluated.

The SCOFF questionnaire illustrates the benefits and limitations of brevity. Morgan, Reid, and Lacey introduced a short screening instrument intended to improve recognition in settings where specialist interviews might be impractical Morgan et al. (1999). Strong performance in an initial case–control sample cannot simply be exported to a low-prevalence community setting: predictive values depend on prevalence, and sensitivity may vary by disorder presentation. Screening cannot resolve diagnostic status, medical instability, or the needs of individuals with presentations outside the tool's original target population.

Modern assessment ideally combines a developmentally appropriate interview, relevant validated scales, medical history, physical examination, contextual history, and functional assessment. Clinicians should investigate possible metabolic, gastrointestinal, neurological, medication-related, or other causes of changed intake where the presentation warrants it. Research studies should report interview training, inter-rater reliability, diagnostic definitions, missing-data procedures, and treatment outcome measures. The diversity of ARFID presentations exemplifies why one measure may not adequately represent the entire construct Kambanis & Thomas (2023) Crone et al. (2023).

Methods for Testing Causation and Longitudinal Course

Observational studies of eating pathology commonly use surveys, clinical cohorts, case-control comparisons, and repeated assessments. Each design answers a different question. A cross-sectional correlation between body dissatisfaction and restrictive behavior cannot establish temporal direction; a longitudinal association provides evidence of precedence but may still be confounded. A randomized trial can estimate the effect of an intervention under its assignment and adherence conditions, while it may leave particular biological or cognitive mediators unresolved. Research synthesis must match the strength of claims to the underlying design Stice et al. (2006) Fairburn et al. (2015).

Outcome selection is especially consequential. Studies variously define recovery through diagnostic remission, abstinence from binge or purging episodes, restoration of nutritional stability, weight change, psychological symptoms, quality of life, or social functioning. A trial may find an effect on one endpoint while effects on another are smaller or unknown. Lock and colleagues, for example, distinguished full and partial remission and evaluated multiple follow-up periods in adolescent anorexia; these operational details are necessary to interpret treatment comparisons Lock et al. (2010).

Attrition, treatment crossover, adherence, nonblinding, and site specialization can affect results. Complex psychotherapy trials often cannot blind participants to assignment, although independent masked outcome assessment can reduce some risk of bias. Pharmacological studies have different safety and masking conditions. For epidemiological syntheses, harmonization of diagnoses and study windows is indispensable. A transparent narrative review states what evidence supports each inference while retaining disagreements and knowledge gaps rather than treating the presence of a DOI as sufficient proof Galmiche et al. (2019) McElroy et al. (2015).

Cognitive-Behavioral Treatment and Comparative Trials

Eating-disorder-focused cognitive-behavioral therapy targets specific maintaining patterns, potentially including dietary rules, binge–compensation cycles, excessive valuation of weight or shape, and unhelpful responses to triggering events. Enhanced cognitive-behavioral therapy (CBT-E) is a transdiagnostic treatment program, but its components, session structure, and target populations must be distinguished from other interventions labeled simply CBT. A two-site trial reported by Fairburn and colleagues evaluated a transdiagnostic approach with extended follow-up and provided important evidence that a common treatment framework can be useful across diagnostic presentations Fairburn et al. (2009).

In a subsequent randomized comparison, Fairburn and colleagues allocated 130 patients to CBT-E or interpersonal psychotherapy, with both treatments delivered across a defined schedule and outcomes evaluated by independent blinded assessors. They reported stronger remission outcomes for CBT-E at the end of treatment, while improvement continued in the interpersonal psychotherapy group over follow-up Fairburn et al. (2015). Interpretation should retain the study's eligibility criteria, attrition, treatment duration, and outcome definitions. The finding favors a particular intervention for a studied outpatient sample rather than establishing that one treatment must supersede all other evidence-based care.

Guidelines vary recommendations by diagnosis and patient group, reflecting differences in trial coverage and clinical risk. NICE discusses guided self-help and focused cognitive-behavioral approaches for adult bulimia and binge-eating disorder, while individual assessment determines whether other interventions or settings are required NICE (2017; updated 2025). Progress must be monitored across eating symptoms, medical state, functioning, and patient-reported outcomes. A common symptom score cannot establish complete recovery when nutritional compromise or serious health consequences persist.

Family-Based Treatment and Developmentally Adapted Care

Family-based treatment for adolescent anorexia centers on supported restoration of eating and progressively appropriate adolescent autonomy within a structured therapeutic framework. Its trial literature is important because the intervention can be operationalized and compared prospectively. In the randomized study conducted by Lock and colleagues, family-based treatment and adolescent-focused individual therapy did not differ on full remission at the end of treatment, but family-based treatment showed advantages on that endpoint at six- and twelve-month follow-ups Lock et al. (2010). This temporal pattern illustrates why trial interpretation must extend beyond immediate posttreatment outcomes.

For adolescent bulimia nervosa, a randomized comparison by Le Grange and colleagues evaluated family-based treatment and adolescent-adapted CBT, with a third supportive psychotherapy condition available for comparison. The investigators reported higher abstinence from bingeing and purging in the family-based group at selected early endpoints Le Grange et al. (2015). The study adds evidence for the clinical relevance of involving families while leaving open questions about long-term outcomes, patient preferences, implementation outside specialized centers, and the distinct treatment needs of patients with severe medical instability.

Family involvement also raises ethical and developmental questions about confidentiality, consent, autonomy, caregiver burden, and access. Family participation can mean different things for young children, independent adults, and patients without safe or available relatives. A research program should compare not merely labels but actual treatment components, caregiver training, therapeutic alliance, and adverse outcomes. The target is sustained functional and physical recovery within the person's social context, with care adapted to developmental needs and clinical safety Crone et al. (2023) NICE (2017; updated 2025).

Pharmacotherapy: Evidence, Indications, and Safety

Drug research in eating disorders is disorder-specific and varies greatly in evidence quality. Pharmacotherapy does not replace a complete assessment of nutrition, medical stability, symptoms, and psychological treatment needs. A randomized placebo-controlled study by Attia and colleagues examined olanzapine in adult outpatients with anorexia nervosa; subsequent evaluations have emphasized the limited scope of evidence concerning weight-related outcomes and uncertainty about broader eating-disorder psychopathology Attia et al. (2019). Regulatory status and intended indication require separate verification before any treatment claim is translated into clinical practice.

For bulimia nervosa, evidence and professional guidelines include fluoxetine within the range of evaluated interventions. For binge-eating disorder, placebo-controlled lisdexamfetamine studies have documented reduction in binge frequency for selected adults, accompanied by adverse-event monitoring and the safety limitations of stimulant medication McElroy et al. (2015). The existence of a positive randomized result establishes effectiveness for an operationalized outcome under particular conditions; it does not establish suitability for an individual or superiority to every psychological alternative. Potential interactions, contraindications, dependence-related considerations, and regulatory authorization require up-to-date official medication documentation.

The American Psychiatric Association guideline and NICE provide structured professional syntheses, while drug-focused evidence reviews discuss divergent strengths of recommendation across syndromes Crone et al. (2023) NICE (2017; updated 2025). Treatment choice should account for comorbidity, age, pregnancy considerations, medical compromise, preference, access, and response to previous care. The present monograph deliberately avoids prescribing instructions or dose schedules. Scientific appraisal focuses on study populations, controls, clinically meaningful outcomes, adverse events, duration of follow-up, and distinctions between approved and off-label uses.

Nutritional Rehabilitation and Levels of Clinical Care

Nutritional rehabilitation is an integral clinical consideration when intake is inadequate, physiological regulation is compromised, or growth has been interrupted. The appropriate setting may range from outpatient multidisciplinary support to intensive or inpatient medical care, depending on severity and stability. Medical monitoring and nutritional intervention are coordinated with psychological treatment because physical and cognitive recovery influence one another. NICE addresses assessment, monitoring, and levels of care for children, young people, and adults, making clinical risk a basis for decisions rather than a secondary concern NICE (2017; updated 2025).

Researchers distinguish physiological stabilization, nutritional adequacy, change in eating-disorder cognitions, and sustained functioning. Improvement in one dimension does not automatically imply improvement in all the others. In particular, restoring intake in severe restriction may require careful management of refeeding-related risk. The ASPEN consensus outlines clinical criteria for recognizing refeeding syndrome and emphasizes risk stratification and monitored practice, while acknowledging variability in definitions and available evidence da Silva et al. (2020). Its recommendations refer to clinical contexts rather than an informal self-treatment protocol.

Service organization can affect measured outcomes: referral delay, availability of specialized teams, continuity after inpatient care, financial access, and engagement with family or social supports all shape recovery trajectories. Comparative effectiveness studies need to adjust for baseline severity because more intensive settings often receive the most medically compromised patients. An observed higher readmission rate in a specialist center, for example, can reflect case mix rather than inferior care. Future trials should incorporate patient-valued outcomes, adverse events, and long-term follow-up Crone et al. (2023) Westmoreland et al. (2016).

Comorbidity, Safety, and Differential Clinical Problems

Feeding and eating disorders frequently interact with depressive symptoms, anxiety, obsessive-compulsive features, trauma-related problems, substance use, and other clinical concerns. The scientific difficulty is that co-occurrence can reflect shared vulnerability, secondary consequences of nutritional disturbance, common environmental stressors, or partially distinct disorders. A high rate of overlap within a treatment clinic cannot alone establish causal relationships in the broader population. Clinical evaluation must therefore assess each relevant condition on its own terms while examining the timeline of eating-related symptoms and physical change Crone et al. (2023) NIMH (n.d.).

Safety assessment extends beyond formal eating-disorder criteria. Severe restriction, dehydration, electrolyte abnormality, medical instability, and self-harm risk can require urgent professional care. The meta-analysis by Arcelus and colleagues demonstrated the substantial mortality burden associated with anorexia nervosa across historical clinical cohorts and reinforced the importance of physical and psychiatric risk assessment Arcelus et al. (2011). Mortality estimates from past cohorts cannot be mechanically translated into an individual's prognosis or into the current population without accounting for recruitment, era, age, severity, and follow-up.

Differential assessment also evaluates other medical explanations for appetite changes, swallowing difficulties, regurgitation, weight change, and vomiting. People can experience both an eating disorder and a separate physical condition, so classification as a psychiatric problem should not foreclose appropriate medical investigation. The strongest practice is interdisciplinary, with shared interpretation of psychological, nutritional, and medical information. For scientific studies, transparent inclusion and exclusion criteria are essential because failure to recognize comorbid medical illness can distort estimates of treatment response Westmoreland et al. (2016) NICE (2017; updated 2025).

Gender, Culture, Athletic Contexts, and Equity in Recognition

Research traditions historically concentrated on adolescent girls and young women, especially within Western clinical settings. These samples helped establish important constructs but cannot support the assumption that the disorders occur exclusively in those groups. Eating disorders are present among men, gender-diverse people, and people of different ages and cultural backgrounds, with variation in symptom expression and help-seeking. Udo and Grilo's representative adult survey offers an example of moving beyond specialist clinical samples while retaining explicit diagnostic definitions Udo & Grilo (2018). Epidemiologic inclusion requires instruments that identify meaningful symptoms without relying on a narrow cultural stereotype.

Appearance concerns may involve thinness, muscularity, athletic performance, or other culturally valued features. Athletes can confront demands involving weight categories, performance, energy availability, and team norms. Restrictive intake may also be shaped by poverty, food insecurity, gastrointestinal conditions, or religious practice, which must be distinguished carefully from eating-disorder psychopathology. The presence of an unusual dietary pattern is not by itself evidence of a disorder. Researchers should evaluate function, medical context, motivation, impairment, and cultural meaning rather than diagnosing through superficial behavior alone NICE (2017; updated 2025) Galmiche et al. (2019).

Equity in research requires multilingual validation, examination of measurement invariance, recruitment across varied service settings, and attention to barriers to care. A scale calibrated on a homogeneous population can produce different false-positive or false-negative rates elsewhere. Weight stigma, shame, disability, and limited treatment access may alter disclosure and recognition. Future studies should directly compare instrument performance and pathways to care across populations instead of interpreting unequal case counts as proof of unequal underlying biological or psychological susceptibility Cooper et al. (1989) Morgan et al. (1999).

Prevention, Early Detection, and Public-Health Research

Prevention studies test whether changing plausible risk factors reduces later eating-disorder symptoms or incidence. Dissonance-based programs invite critical evaluation of appearance ideals, attempting to diminish their internalization and downstream body dissatisfaction. In a randomized trial involving 481 adolescent girls with body concerns, Stice and colleagues compared dissonance-focused and healthy-weight prevention programs with expressive writing and assessment-only control conditions Stice et al. (2006). The investigators observed reductions in several risk indicators and symptoms, while comparative advantages varied with follow-up interval. These findings support targeted intervention research and the need for repeated outcomes.

Early recognition depends on improving professional knowledge and lowering barriers to confidential assessment. A screening instrument may be useful when it prompts an appropriate clinical interview, but screening performance depends on base rates and population characteristics. Morgan and colleagues' development of SCOFF illustrates an initial attempt to simplify detection while highlighting the need for later field validation Morgan et al. (1999). For ARFID, the developing assessment literature still lacks an unequivocal leading measure for tracking all presentations across treatment Kambanis & Thomas (2023). Public-health programs must account for both phenomena rather than applying a single screening protocol universally.

Preventive policy also faces evaluation problems. Increases in referrals or recorded diagnoses following an awareness campaign can indicate better case recognition, growing burden, or both. Programs should collect baseline measures, predefined outcomes, adverse-event information, and sufficiently long follow-up. Research must assess whether symptom reductions translate into fewer new cases, better functioning, earlier access to care, and equitable benefit across communities. Prevention is best understood as a testable service and social intervention, not a promise that any one message can remove all etiological risk Stice et al. (2006) Galmiche et al. (2019).

Evidence Synthesis: What Is Established and What Remains Conditional

Several conclusions are well supported across distinct evidence streams. Feeding and eating disorders constitute clinically significant and heterogeneous syndromes with demonstrable psychological and medical consequences. Structured clinical assessment and safety evaluation are necessary. Randomized evidence supports focused psychological interventions for major eating-disorder presentations, including CBT-based approaches and family-based treatment for selected adolescent conditions. Pharmacological trials identify benefits for certain disorders and outcomes while requiring separate safety assessment. These conclusions derive from intervention studies, clinical research, and guideline synthesis rather than from one comprehensive theory of etiology Crone et al. (2023) Fairburn et al. (2015) Lock et al. (2010) McElroy et al. (2015).

A second set of propositions remains conditional. Genetic findings support biological liability in anorexia, but causal pathways are incompletely established. Body-image and emotion-related constructs contribute to important explanatory models, but their importance varies across syndromes. Restriction and starvation can transform cognition, complicating temporal interpretation. For ARFID, pica, and rumination disorder, the evidence base is uneven and some interventions lack large, replicated randomized trials. A review should not treat a persuasive mechanism, a promising small study, and a clinically validated treatment as equivalent levels of evidence Watson et al. (2019) Kambanis & Thomas (2023).

The most difficult questions concern causal heterogeneity, long-term remission, prevention of recurrence, comparative safety, and generalization across underserved groups. Evidence from short-term specialist trials may not reproduce in primary care or resource-constrained settings. Diagnostic categories do not necessarily map onto singular biological or psychological mechanisms, and the same symptom score can reflect different lived experiences. Investigators should favor transparent operational definitions, prespecified analyses, replication, meaningful functioning endpoints, and documentation of adverse outcomes Galmiche et al. (2019) NICE (2017; updated 2025).

Research Frontiers: Measurement, Mechanisms, and Care Systems

An important priority is longitudinal research beginning before symptom onset and continuing through illness, treatment, remission, and possible recurrence. Repeated clinical, behavioral, nutritional, and physiological measures can distinguish premorbid liability from consequences of undernutrition or distress. Large diverse cohorts would permit examination of subgroup-specific pathways without assuming that broad diagnostic categories are mechanistically homogeneous. Genetic research could be integrated with environmental measures under designs capable of testing interaction hypotheses rather than merely reporting statistical overlap Watson et al. (2019).

Another priority is comparative intervention research with meaningful outcomes. Studies should compare established therapies in varied health systems, document treatment fidelity and patient preferences, include functional recovery, and examine effects beyond the immediate treatment period. For ARFID and related feeding conditions, rigorous randomized trials and improved cross-age measurement could substantially improve current knowledge Kambanis & Thomas (2023). For medication, maintenance, discontinuation, adverse events, and interaction with psychotherapy remain essential research domains. Reproducible methods and independent replication should guide the relative weight assigned to novel findings.

The Artificial Era adds a technologically mediated research context. Digital food diaries, remote assessment, conversational systems, online communities, and algorithmic recommendations may affect symptom monitoring, social comparison, and access to help. Their scientific evaluation requires clear human welfare outcomes, privacy safeguards, population validation, and active assessment of harm. Systems that encourage restrictive routines or reinforce dangerous behaviors could increase risk, while properly governed tools might support referral and continuity of care. Claims of benefit demand independent intervention research; technological sophistication is not evidence of clinical effectiveness. This domain links the dossier to broader studies of human–artificial relations without shifting its core clinical research object.

Conclusion

Feeding and eating disorders constitute a heterogeneous domain unified by clinically consequential disturbances of intake, eating behavior, and related psychological functioning. The field developed from early descriptions of severe restriction into an expanded framework covering binge–compensation cycles, recurrent loss-of-control eating, sensory and fear-based avoidance, pica, rumination, and other clinically important presentations. Its explanatory models draw on cognition, emotion, learning, interpersonal processes, developmental conditions, neurobiology, genetics, and sociocultural environments. Their integration depends on attending to clinical differences and evaluating each proposed mechanism through the design that can test it Pearce (2004) Russell (1979) Kambanis & Thomas (2023).

The evidence establishes serious medical risks, the value of structured interdisciplinary assessment, and the effectiveness of several defined psychological treatments in appropriate populations. Family-based approaches for selected adolescents and cognitive-behavioral methods for multiple eating-disorder presentations possess randomized research support; selected medication studies add disorder-specific evidence within important safety and regulatory boundaries. The scientific record also contains uncertainty regarding treatment selection, relapse prevention, biological pathways, external validity, and effective care for less extensively studied feeding disorders Lock et al. (2010) Fairburn et al. (2015) Attia et al. (2019) Crone et al. (2023).

The resulting synthesis supports a research program centered on clear definitions, long-term repeated measurement, comparative clinical trials, mechanism testing, and equitable access to evidence-based care. Scientific progress will require closer integration of medical, behavioral, developmental, and social evidence while preserving the distinction between the success of an intervention and proof of its proposed causal theory. Feeding and Eating Disorders is therefore a continuing scientific inquiry into how bodily regulation, psychological meaning, and social organization interact across changing patterns of eating and recovery.

References

  • Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Archives of General Psychiatry, 68(7), 724–731. https://doi.org/10.1001/archgenpsychiatry.2011.74
  • Attia, E., Steinglass, J. E., Walsh, B. T., Wang, Y., Wu, P., Schreyer, C., Wildes, J., Yilmaz, Z., Guarda, A. S., Kaplan, A. S., & Marcus, M. D. (2019). Olanzapine versus placebo in adult outpatients with anorexia nervosa: A randomized clinical trial. American Journal of Psychiatry, 176(6), 449–456. https://doi.org/10.1176/appi.ajp.2018.18101125
  • Cooper, Z., Cooper, P. J., & Fairburn, C. G. (1989). The validity of the Eating Disorder Examination and its subscales. British Journal of Psychiatry, 154, 807–812. https://doi.org/10.1192/bjp.154.6.807
  • Crone, C., Fochtmann, L. J., Attia, E., Boland, R., Escobar, J., Fornari, V., Golden, N., Guarda, A., Jackson-Triche, M., Manzo, L., Mascolo, M., Pierce, K., Riddle, M., Seritan, A., Uniacke, B., Zucker, N., Yager, J., Craig, T. J., Hong, S.-H., & Medicus, J. (2023). The American Psychiatric Association practice guideline for the treatment of patients with eating disorders. American Journal of Psychiatry, 180(2), 167–171. https://doi.org/10.1176/appi.ajp.23180001
  • da Silva, J. S. V., Seres, D. S., Sabino, K., Adams, S. C., Berdahl, G. J., Citty, S. W., Cober, M. P., Evans, D. C., Greaves, J. R., Gura, K. M., Michalski, A., Plogsted, S., Sacks, G. S., Tucker, A. M., Worthington, P., Walker, R. N., & Ayers, P. (2020). ASPEN consensus recommendations for refeeding syndrome. Nutrition in Clinical Practice, 35(2), 178–195. https://doi.org/10.1002/ncp.10474
  • Fairburn, C. G., Cooper, Z., Doll, H. A., O’Connor, M. E., Bohn, K., Hawker, D. M., Wales, J. A., & Palmer, R. L. (2009). Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: A two-site trial with 60-week follow-up. American Journal of Psychiatry, 166(3), 311–319. https://doi.org/10.1176/appi.ajp.2008.08040608
  • Fairburn, C. G., Bailey-Straebler, S., Basden, S., Doll, H. A., Jones, R., Murphy, R., O’Connor, M. E., & Cooper, Z. (2015). A transdiagnostic comparison of enhanced cognitive behaviour therapy (CBT-E) and interpersonal psychotherapy in the treatment of eating disorders. Behaviour Research and Therapy, 70, 64–71. https://doi.org/10.1016/j.brat.2015.04.010
  • Galmiche, M., Déchelotte, P., Lambert, G., & Tavolacci, M. P. (2019). Prevalence of eating disorders over the 2000–2018 period: A systematic literature review. American Journal of Clinical Nutrition, 109(5), 1402–1413. https://doi.org/10.1093/ajcn/nqy342
  • Kambanis, P. E., & Thomas, J. J. (2023). Assessment and treatment of avoidant/restrictive food intake disorder. Current Psychiatry Reports, 25(2), 53–64. https://doi.org/10.1007/s11920-022-01404-6
  • Le Grange, D., Lock, J., Agras, W. S., Bryson, S. W., & Jo, B. (2015). Randomized clinical trial of family-based treatment and cognitive-behavioral therapy for adolescent bulimia nervosa. Journal of the American Academy of Child & Adolescent Psychiatry, 54(11), 886–894.e2. https://doi.org/10.1016/j.jaac.2015.08.008
  • Lock, J., Le Grange, D., Agras, W. S., Moye, A., Bryson, S. W., & Jo, B. (2010). Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Archives of General Psychiatry, 67(10), 1025–1032. https://doi.org/10.1001/archgenpsychiatry.2010.128
  • McElroy, S. L., Hudson, J. I., Mitchell, J. E., Wilfley, D., Ferreira-Cornwell, M. C., Gao, J., Wang, J., Whitaker, T., Jonas, J., & Gasior, M. (2015). Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: A randomized clinical trial. JAMA Psychiatry, 72(3), 235–246. https://doi.org/10.1001/jamapsychiatry.2014.2162
  • Morgan, J. F., Reid, F., & Lacey, J. H. (1999). The SCOFF questionnaire: Assessment of a new screening tool for eating disorders. BMJ, 319(7223), 1467–1468. https://doi.org/10.1136/bmj.319.7223.1467
  • National Institute for Health and Care Excellence. (2017; minor revisions through 2025). Eating disorders: Recognition and treatment (NICE guideline NG69). https://www.nice.org.uk/guidance/ng69
  • National Institute of Mental Health. (n.d.). Eating disorders: What you need to know. National Institutes of Health. https://www.nimh.nih.gov/health/publications/eating-disorders
  • Pearce, J. M. S. (2004). Richard Morton: Origins of anorexia nervosa. European Neurology, 52(4), 191–192. https://doi.org/10.1159/000082033
  • Russell, G. (1979). Bulimia nervosa: An ominous variant of anorexia nervosa. Psychological Medicine, 9(3), 429–448. https://doi.org/10.1017/S0033291700031974
  • Stice, E., Shaw, H., Burton, E., & Wade, E. (2006). Dissonance and healthy weight eating disorder prevention programs: A randomized efficacy trial. Journal of Consulting and Clinical Psychology, 74(2), 263–275. https://doi.org/10.1037/0022-006X.74.2.263
  • Udo, T., & Grilo, C. M. (2018). Prevalence and correlates of DSM-5-defined eating disorders in a nationally representative sample of U.S. adults. Biological Psychiatry, 84(5), 345–354. https://doi.org/10.1016/j.biopsych.2018.03.014
  • Vandereycken, W., & van Deth, R. (1989). Who was the first to describe anorexia nervosa: Gull or Lasègue? Psychological Medicine, 19(4), 837–845. https://doi.org/10.1017/S0033291700005559
  • Watson, H. J., Yilmaz, Z., Thornton, L. M., Hübel, C., Coleman, J. R. I., Gaspar, H. A., Bryois, J., Hinney, A., Leppä, V., Mattheisen, M., et al. (2019). Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa. Nature Genetics, 51(8), 1207–1214. https://doi.org/10.1038/s41588-019-0439-2
  • Westmoreland, P., Krantz, M. J., & Mehler, P. S. (2016). Medical complications of anorexia nervosa and bulimia. American Journal of Medicine, 129(1), 30–37. https://doi.org/10.1016/j.amjmed.2015.06.031